Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas
Wednesday, June 17, 2026Zai Lab Limited NASDAQ ZLAB HKEX today announced the European Medicines Agency EMA has granted Orphan Drug Designation ODD to zocilurtatug pelitecan zoci formerly ZL the Companys
USP and BPOM Open Registration for Joint Symposium on Pharmaceutical Quality and Regulatory Excellence in Jakarta
Wednesday, June 17, 2026The United States Pharmacopeia USP and Badan Pengawas Obat dan Makanan BPOM the Indonesian Food and Drug Authority invite regulators industry players manufacturers and academic stakeholders to register
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry
Tuesday, June 16, 2026Pelago Bioscience a specialist drug discovery focused contract research organization CRO known for its industryleading cellbased target engagement assays is pleased to announce the acquisition of RG Discovery
Lilly's Jaypirca significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Tuesday, June 16, 2026Eli Lilly and Company NYSE LLY today announced results from the Phase BRUIN CLL clinical trial of Jaypirca pirtobrutinib a noncovalent Bruton tyrosine kinase BTK inhibitor plus venetoclax and rituximab versus
MattenPlant Expands into Pharmaceutical Water Solutions with Southeast Asia's First Locally Manufactured Cold WFI System at SIWW 2026
Tuesday, June 16, 2026MattenPlant Pte Ltd Matten a Singaporebased specialist in industrial and municipal water and wastewater treatment announces the launch of its Pharmaceutical Water for Injection Cold WFI initiative bringing
QIAGEN receives ARTG inclusion for QIAstat-Dx Meningitis/Encephalitis Panel to support rapid diagnosis in Australia
Monday, June 15, 2026QIAGEN today announced that its QIAstatDx MeningitisEncephalitis ME Panel has been included in the Australian Register of Therapeutic Goods ARTG The inclusion marks rapid molecular testing for the detection of pathogens
Shaping Smart & Future-Ready Pharma Through Global Vision and Local Agility
Monday, June 15, 2026As the pharmaceutical and biopharmaceutical industries navigate unprecedented technological regulatory and operational change the ability to balance global innovation with local execution has become a defining competitive advantage
DKSH Partners with BridgeBio to Advance Regulatory Review and Potential Access to ATTR-CM Therapy Across Selected Asia-Pacific Markets
Friday, June 12, 2026DKSH entered a strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient access to a Transthyretin Stabilizer for ATTRCM in Australia Singapore South Korea
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
Friday, June 12, 2026Roche SIX RO ROP OTCQX RHHBY announced today the European Union In Vitro Diagnostic Regulation IVDR approval of several label expansions for the VENTANA MMR RxDx Panel an immunohistochemistry
Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
Friday, June 12, 2026Akeso Inc HK today announced that the National Medical Products Administration NMPA of China has approved gumokimab AK the companys internallydeveloped antiIL monoclonal antibody
